Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding

Molecular and Cellular Biology

Volumn 19, Issue 3, 1999, Pages 2155-2168

  Janus, Friedemann ^a   Albrechtsen, Nils ^a   Knippschild, Uwe ^a   Wiesmüller, Lisa ^a   Grosse, Frank ^b   Deppert, Wolfgang ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPITOPE; EXONUCLEASE; MONOCLONAL ANTIBODY; PROTEIN P53;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA RECOMBINATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; INSECT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN;

ANIMALIA; INSECTA;

EID: 0033019052     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.3.2155     Document Type: Article

References (71)

1. Bakalkin, G., G. Selivanova, T. Yakovleva, E. Kiseleva, E. Kashuba, K. P. Magnusson, L. Szekely, G. Klein, L. Terenius, and K. G. Wiman. 1995. p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res. 23:362-369.
2. Bakalkin, G., T. Yakovleva, G. Selivanova, K. P. Magnusson, L. Szekely, E. Kiseleva, G. Klein, L. Terenius, and K. G. Wiman. 1994. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA 91:413-417.
3. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild-type p53 activity. EMBO J. 12:461-468.
4. Bargonetti, J., J. J. Manfredi, X. Chen, D. R. Marshak, and C. Prives. 1993. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activily when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7:2565-2574.
5. Bargonetti, J., I. Reynisdottir, P. N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6:1886-1898.
6. Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355.
7. DeLeo, A. B., H. Shiku, T. Takahashi, M. John, and L. J. Old. 1977. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J. Exp. Med. 146:720-734.
8. Dudenhoeffer, C., G. Rohaly, K. Will, W. Deppert, and L. Wiesmueller. 1998. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol. Cell. Biol. 18:5332-5342.
9. El-Deiry, W. S., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
10. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
11. Eliyahu, D., N. Goldfinger, O. Pinhasi-Kimhi, G. Shaulsky, Y. Skurnik, N. Arai, V. Rotter, and M. Oren. 1988. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3:313-321.
12. Fiscella, M., S. J. Ullrich, N. Zambrano, M. T. Shields, D. Lin, S. P. Lees-Miller, C. W. Anderson, W. E. Mercer, and E. Appella. 1993. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 8:1519-1528.
13. Fritsche, M., C. Haessler, and G. Brandner. 1993. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307-318.
14. Fuchs, B., D. Hecker, and K. H. Scheidtmann. 1995. Phosphorylation studies on rat p53 using the baculovirus expression system - manipulation of the phosphorylation state with okadaic acid and influence on DNA binding. Eur. J. Biochem. 228:615-639.
15. Gannon, J. V., R. Greaves, R. Iggo, and D. P. Lane. 1990. Activating mutations in p53 produce a common informational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9:1595-1602.
16. Halazonetis, T. D., and A. N. Kandil. 1993. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J. 12:5057-5064.
17. Hansen, S., T. R. Hupp, and D. P. Lane. 1996. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. J. Biol. Chem. 271:3917-3924.
18. Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39: 861-869.
19. Harper, J. W., G. R. Adami, M. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
20. Hecker, D., G. Page, M. Lohrum, S. Weiland, and K. H. Scheidtmann. 1996. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene 12:953-961.
21. Huang, P. 1998. Excision of mismatched nucleotides from DNA: a potential mechanism for enhancing DNA replication fidelity by the wild-type p53 protein. Oncogene 17:261-270.
22. Hupp, T. R., and D. P. Lane. 1994. Allosteric activation of latent p53 tetramers. Curr. Biol. 4:865-875.
23. Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1993. Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res. 21:3167-3174.
24. Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
25. Janus, F., N. Albrechtsen, I. Dornreiter, L. Wiesmüller, F. Grosse, and W. Deppert. The dual role model for p53 in maintaining genomic integrity. Cell. Mol. Life Sci., in press.
26. Jayaraman, L., and C. Prives. 1995. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81:1021-1029.
27. Jiang, D., A. Srinivasan, G. Lozano, and P. D. Robbins. 1993. SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene 8:2805-2812.
28. Kastan, M. B., Q. Zhan, W. D. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597.
29. Kim, E., N. Albrechtsen, and W. Deppert. 1997. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53. Oncogene 15:857-869.
30. Ko, L. J., S. Y. Shieh, X. B. Chen, L. Jayaraman, K. Tamai, Y. Taya, C. Prives, and Z. Q. Pan. 1997. p53 is phosphorylated by Cdk7-cyclin H in a p36mat1-dependent manner. Mol. Cell. Biol. 17:7220-7229.
31. Kornberg, A., and T. Baker. 1991. DNA replication, 2nd ed. W. H. Freeman, San Francisco, Calif.
32. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491-7495.
33. Kühn, C., F. Müller, C. Meller, H.-P. Nasheue, F. Janus, W. Deppert, and F. Grosse. Surface plasma resonance measurements reveal stable complex formation between p53 and DNA polymerase α, Oncogene, in press.
34. Kulesz-Martin, M. F., B. Lisafeld, H. Huang, N. D. Kisiel, and L. Lee. 1994. Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells. Mol. Cell. Biol. 14:1698-1708.
35. Lane, D. P. 1993. Cancer: a death in the life of p53. Nature 362:786-787.
36. Lane, D. P. 1992. Cancer: p53, guardian of the genome. Nature 358:15-16.
37. Lane, D. P., C. W. Stephen, C. A. Midgley, A. Sparks, T. R. Hupp, D. A. Daniels, R. Greaves, A. Reid, B. Vojtesek, and S. M. Picksley. 1996. Epitope analysis of the murine p53 tumour suppressor protein. Oncogene 12:2461-2466.
38. Lee, S., B. Elenbaas, A. Levine, and J. Griffith. 1995. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81:1013-1020.
39. Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.
40. Linn, S. M., R. S. Lloyd, and R. J. Roberts. 1993. Nucleases, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
41. Lohrum, M., and K. H. Scheidtmann. 1996. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes. Oncogene 13:2527-2539.
42. Marx, J. 1993. How p53 suppresses cell growth. Science 262:1644-1645.
43. Mietz, J. A., T. Unger, J. M. Huibregtse, and P. M. Howley. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:5013-5020.
44. Milne, D. M., L. McKendrick, L. J. Jardine, E. Deacon, J. M. Lord, and D. W. Meek. 1996. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate. Oncogene 13:205-211.
45. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
46. Mol, C. D., C. F. Kuo, M. M. Thayer, R. P. Cunningham, and J. A. Tainer. 1995. Structure and function of the multifunctional DNA-repair enzyme exonuclease III. Nature 374:381-386.
47. Molinari, M., A. L. Okorokov, and J. Milner. 1996. Interaction with damaged DNA induces selective proteolytic cleavage of p53 to yield 40 kDa and 35 kDa fragments competent for sequence-specific DNA binding. Oncogene 13:2077-2086.
48. Muller, C. W., and S. C. Harrison. 1995. The structure of the NF-kappa B p560:DNA-complex: a starting point for analyzing the Rel family. FEBS Lett. 369:113-117.
49. Mummenbrauer, T., F. Janus, B. Mueller, L. Wiesmueller, W. Deppert, and F. Grosse. 1996. p53 protein exhibits 3′-to-5′ exonuclease activity. Cell 85: 1089-1099.
50. Oberosler, P., P. Hloch, U. Ramsperger, and H. Stahl. 1993. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12: 2389-2396.
51. Okorokov, A. L., F. Ponchel, and J. Milner. 1997. Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53. EMBO J. 16:6008-6017.
52. Pavletich, N. P., K. A. Chambers, and C. O. Pabo. 1993. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev. 7:2556-2564.
53. Pietenpol, J. A., and B. Vogelstein. 1993. Tumor suppressor genes: no room at the p53 inn. Nature 365:17-18.
54. Scheidtmann, K. H., M. C. Mumby, K. Rundell, and G. Walter. 1991. Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol. Cell. Biol. 11:1996-2003.
55. Schmieg, F. I., and D. T. Simmons. 1988. Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding site. Virology 164:132-140.
56. Scolnick, D. M., N. H. Chehab, E. S. Stavridi, M. C. Lien, L. Caruso, E. Moran, S. L. Berger, and T. D. Halazonetis. 1997. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:3693-3696.
57. Shaw, P., J. Freeman, R. Bovey, and R. Iggo. 1996. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12:921-930.
58. Slingerland, J. M., J. R. Jenkins, and S. Benchimol. 1993. The transforming and suppressor functions of p53 alleles: Effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J. 12: 1029-1037.
59. Stephen, C. W., P. Helminen, and D. P. Lane. 1995. Characterization of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. J. Mol. Biol. 248:58-78.
60. Stephen, C. W., and D. P. Lane. 1992. Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. J. Mol. Biol. 225:577-583.
61. Stürzbecher, H. W., R. Brain, C. Addison, K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J. R. Jenkins. 1992. A C-terminal a-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7:1513-1523.
62. Tarunina, M., and J. R. Jenkins. 1993. Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity. Oncogene 8:3165-3173.
63. Tavormina, P. A., Y. Wang, and D. J. Burke. 1997. Differential requirements for DNA replication in the activation of mitotic check points in Saccharomyces cerevisiae. Mol. Cell. Biol. 17:3315-3322.
64. Unger, T., J. A. Mietz, M. Scheffner, C. L. Yee, and P. M. Howley. 1993. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell. Biol. 13:5186-5194.
65. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526.
66. Wade-Evans, A., and J. R. Jenkins. 1985. Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J. 4:699-706.
67. Wang, Y., and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376:88-91.
68. Wang, Y., M. Reed, P. Wang, J. E. Stenger, G. Mayr, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer. 1993. p53 domain: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7:2575-2586.
69. Wiesmüller, L., J. Cammenga, and W. Deppert. 1996. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J. Virol. 70:737-744.
70. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-2232.
71. Yewdell, J. W., J. V. Gannon, and D. P. Lane. 1986. Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol. 59:444-452.